This inventor holds 1 USPTO granted patent, plus 3 CIPO patents. Top assignee: Novagali Pharma Sa. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: Severine Bague: Innovator in Ophthalmic Emulsions
Introduction
Severine Bague is a notable inventor based in Marcoussis, France. She has made significant contributions to the field of ophthalmology through her innovative work on emulsions designed for eye treatments. Her research focuses on developing effective solutions for dry eye diseases, which affect millions of people worldwide.
Latest Patents
Severine Bague holds a patent for "Ophthalmic emulsions containing an immunosuppressive agent." This patent describes ophthalmic oil-in-water emulsions that comprise colloid particles with an oily core surrounded by an interfacial film. The emulsion includes an immunosuppressive agent, an oil—preferably at least 50% of which is medium-chain triglycerides (MCT)—and tyloxapol. This formulation is intended for use in the manufacture of medicaments aimed at treating various eye conditions, particularly dry eye diseases.
Career Highlights
Severine Bague is associated with Novagali Pharma, a company dedicated to developing innovative ophthalmic products. Her work has been instrumental in advancing the understanding and treatment of eye conditions, showcasing her commitment to improving patient care.
Collaborations
Severine collaborates with talented professionals in her field, including Gregory Lambert and Laura Rabinovich-Guilatt. Their combined expertise contributes to the success of their projects and the development of groundbreaking treatments.
Conclusion
Severine Bague's contributions to ophthalmic emulsions represent a significant advancement in the treatment of eye conditions. Her innovative approach and dedication to research continue to impact the field positively.